Cardiovascular Systems Inc  

(Public, NASDAQ:CSII)   Watch this stock  
Find more results for CSII
38.59
-0.39 (-1.00%)
Apr 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 38.04 - 39.06
52 week 23.15 - 41.28
Open 38.72
Vol / Avg. 147,985.00/201,885.00
Mkt cap 1.22B
P/E     -
Div/yield     -
EPS -1.06
Shares 31.61M
Beta 0.74
Inst. own 73%
Apr 29, 2015
Q3 2015 Cardiovascular Systems Inc Earnings Call - 4:45PM EDT - Add to calendar
Apr 29, 2015
Q3 2015 Cardiovascular Systems Inc Earnings Release - 4:00PM EDT - Add to calendar
Apr 14, 2015
Cardiovascular Systems Inc at Needham Healthcare Conference
Mar 11, 2015
Cardiovascular Systems Inc at Barclays Healthcare Conference - Webcast
Feb 11, 2015
Cardiovascular Systems Inc at Leerink Global Healthcare Conference
Jan 28, 2015
Q2 2015 Cardiovascular Systems Inc Earnings Call - Webcast
Jan 28, 2015
Q2 2015 Cardiovascular Systems Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin -11.79% -25.83%
Operating margin -11.74% -24.51%
EBITD margin - -23.51%
Return on average assets -11.65% -25.32%
Return on average equity -14.26% -32.24%
Employees 479 -
CDP Score - -

Address

1225 Old Highway 8 NW
SAINT PAUL, MN 55112-6416
United States - Map
+1-651-2591600 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Cardiovascular Systems, Inc., is a medical device company. The Company is engaged in developing and commercializing innovative solutions for treating peripheral and coronary vascular disease. The Company�s primary focus is helping physicians conquer even the most difficult disease states, including calcium, given the complications it presents for the millions who suffer from peripheral arterial disease (PAD) and coronary artery disease (CAD). The Company�s PAD products include Stealth 360� Peripheral Orbital Atherectomy System (OAS) (Stealth 360), Diamondback 360 Peripheral OAS (Diamondback 360 Peripheral) and Diamondback Predator 360� (the Predator 360). The Company�s CAD product includes Diamondback 360 Coronary OAS (CAD System).

Officers and directors

David L. Martin President, Chief Executive Officer, Director
Age: 49
Bio & Compensation  - Reuters
Laurence L. Betterley Chief Financial Officer
Age: 60
Bio & Compensation  - Reuters
Kevin J. Kenny Executive Vice President - Sales & Marketing
Age: 49
Bio & Compensation  - Reuters
Paul Koehn Senior Vice President - Quality and Operations
Age: 51
Bio & Compensation  - Reuters
Robert J. Thatcher Chief Healthcare Policy Officer
Age: 59
Bio & Compensation  - Reuters
William E Cohn Director
Bio & Compensation  - Reuters
Scott A. Bartos Independent Director
Age: 51
Bio & Compensation  - Reuters
Brent G. Blackey Independent Director
Age: 55
Bio & Compensation  - Reuters
Edward M. Brown Independent Director
Age: 51
Bio & Compensation  - Reuters
Augustine J. Lawlor Independent Director
Age: 58
Bio & Compensation  - Reuters